| CYSB2000360 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(原7) | Supplementary Application | 2020-12-18 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2020-12-16 | view |
| CYSB2000359 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(原7) | Supplementary Application | 2020-12-18 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2020-12-16 | view |
| CXSS2000058 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(3.4) | New Drug Application | 2020-11-27 | 山东新时代药业有限公司 | Shandong New Time Pharmaceutical Co Ltd | In Review | 2020-11-26 | view |
| CYSB2000072 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2020-04-22 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2020-07-16 | view |
| CYSB2000073 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2020-04-22 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2020-07-16 | view |
| CXSS2000009 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(15) | New Drug Application | 2020-03-19 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-03-17 | view |
| CYSB2000016 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2020-02-14 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2020-03-26 | view |
| CYSB1700216 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2018-06-15 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2019-06-26 | view |
| CYSB1700181 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2017-11-16 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2017-11-14 | view |
| CXSL1700016 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(15) | New Drug Application | 2017-03-30 | 合肥天麦生物科技发展有限公司 | Hefei Tianmai BIOTECHNOLOGY Development Co Ltd | Certificate Issued | 2018-04-10 | view |
| CYSB1500535 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2016-09-18 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2017-09-14 | view |
| CXSL1300053 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(15) | New Drug Application | 2013-10-28 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2015-07-13 | view |
| CXSL1300007 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(15) | New Drug Application | 2013-07-01 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2016-01-13 | view |
| JXSL1200009 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Import Drug Application | 2012-02-14 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2014-01-30 | view |
| CXSS1100016 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(15) | New Drug Application | 2011-08-31 | 山东新时代药业有限公司 | Shandong New Time Pharmaceutical Co Ltd | Certificate Issued | 2016-03-10 | view |
| CYSB1100044 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2011-06-07 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2014-06-05 | view |
| CXSL0900030 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products(15) | New Drug Application | 2010-02-08 | 珠海联邦制药股份有限公司中山分公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2011-09-29 | view |
| CXSB0700035 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2007-09-12 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2008-04-18 | view |
| CXSB0500151 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2005-11-23 | 山东新时代药业有限公司 | Shandong New Time Pharmaceutical Co Ltd | In Approval | 2011-08-04 | view |
| CXSB0500150 | 重组甘精胰岛素注射液 | Recombinant Insulin Glargine | Injection | Biological Products | Supplementary Application | 2005-11-23 | 山东新时代药业有限公司 | Shandong New Time Pharmaceutical Co Ltd | In Approval | 2011-08-04 | view |
